MEA Pigmented Lesion Treatment Market

Middle East and Africa Pigmented Lesion Treatment Market Size (2024 to 2029)

The size of the pigmented lesion treatment market in the Middle East and Africa is estimated to witness a healthy CAGR from 2024 to 2029.

Growing stipulations for treatment procedures for quick healing and the existence of well-established healthcare infrastructure are stimulating market growth. The growing necessity for dermatology techniques and increasing beauty consciousness in both men and women is predicted to drive the market. People aged 60 years and above are stimulated to augment around 2050, according to the World Health Organization (WHO). Advanced technologies in therapy processes comprising laser and energy-based treatments for pigmented lesions are likely to expand the market growth. The latest and newly introduced therapies can remove forms of skin effects of the vascular and pigmented lesion with no side effects.

A laser treatment used at the time of treating patients may have some side-effects like skin itching, rashes, scar, skin becomes red, and swelling of the skin, and in some rare cases, infections and hyperpigmentation can occur, which may hamper the growth. The cost associated with the pigmented lesion treatment is very expensive, which is unaffordable. Lack of knowledge about the treatment is limiting the demand of the market.

This research report on the MEA Pigmented Lesion Treatment Market has been segmented and sub-segmented into the following categories.

Middle East and Africa Pigmented Lesion Treatment Market - By Product

• Energy-Based Devices
• RF Devices
• Ultrasound Devices
• IPL Devices

Middle East and Africa Pigmented Lesion Treatment Market - By End User 

• Beauty Clinics
• Dermatology Clinics

Middle East and Africa Pigmented Lesion Treatment Market - By Country 

• KSA
• UAE
• Israel
• Rest of the GCC countries
• South Africa
• Ethiopia
• Kenya
• Egypt
• Sudan
• Rest of MEA

The Middle East & Africa region is accounted to have steady, minimal, and average growth rates over the period. It is estimated to project a healthy growth rate in the upcoming years. The growth is ascribed due to factors like varying lifestyles, growing cravings for smoking, and increased alcohol intake. Also, escalation in an inactive lifestyle and expenses on the region's healthcare services domain may impel the market growth.

UAE is projected to lead the pigmented lesion treatment in the MEA region. Factors like the rising population of the old people population, the growing assumption of human-made cosmetic commodities, and the presentation of experimental medications and therapy are likely to surge the region's market growth. Africa is forecasted to have rapid growth in the pigmented lesion treatment market of MEA. 1in every 5,000 to 15,000 people in Africa have albinism. The frequency of albinism is high in African countries. An increasing number of hospitals and dermatology clinics, exposure to heavy sun rays, and the introduction of non-invasive med-aesthetic systems that can efficiently decrease the consequences drive the market growth in MEA.

KEY MARKET PLAYERS

Companies that play a dominating role in the Middle East and Africa pigmented lesion treatment market include Alma Lasers Ltd., Lumenis Ltd., Cynosure, Inc., Strata Skin Sciences Inc., Fotona d.d., Sciton, Inc., EL.En. S.p.A., Lynton Lasers Ltd, Solta Medical Inc., Syneron Medical Ltd., Lutronic Corporation, and Cutera Inc.